Thus, a high level of TIE-2+ M-MDSC/ANGPT2 in peripheral blood is associated with impaired antitumor T-cell responses in advanced melanoma, suggesting that this proangiogenic pathway may suppress tumor-specific T cell in melanoma. This evidence concerns the gene ANGPT2 and neoplasm.